Amiodarone is a class III antiarrhythmic agent with a long half-life which is used to control
atrial and ventricular arrhythmias, including atrial flutter and fibrillation. We describe here the …

We report a case of intravenous (IV) amiodarone drug induced liver injury (DILI). The patient
received IV N-acetylcysteine (NAC) which resulted in a rapid improvement in liver enzymes …

Cholestasis has been reported as a rare presentation among patients with severe liver injury
secondary to amiodarone hepatic toxicity. We report an unusual case of amiodarone …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

We present a case report of an 80-year-old woman with volume overload thought initially to
be secondary to heart failure, but determined to be amiodarone-induced acute and chronic …

A 64-year-old man developed a fulminant hepatitis 4 days after initiation of amiodarone
treatment and a total dose of 7.1 g. The direct Coombs test was positive and became …

We report a patient with classical features of amiodarone hepatotoxicity who died of
progressive liver failure. Throughout the course of his illness, he had epigastric pain …

The evolving spectrum of amiodarone hepatotoxicity Page 1 HEPATOLOGY 116 HEPATOLOGY
ELSEWHERE timately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl …

Background: Hepatotoxicity due to intravenous amiodarone (HIVAD) is a rare side effect with
a distinct pattern of enzyme disturbances compared to liver damage from oral amiodarone …

This cross-sectional, retrospective study was designed to evaluate the current clinical
applications and acute hepatotoxicity of intravenous amiodarone administration at a hospital …